DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

Molecular Imaging Homepage

New imaging system may accelerate drug development for Alzheimer's cryo-MOST provides more detail than MR and PET

Phase I trial demonstrates safe use of radiotracer produced in minutes Manufactured using a Ga-68 generator and a cold kit vial

Bracco Imaging acquires SurgVision Enables development of a real-time fluorescence image-guided surgery platform

Blue Earth Diagnostics inks Axumin deal with Seibersdorf Laboratories Manufacturing and distribution in certain European countries

Two new imaging agents may help physicians make better and quicker treatment decisions Could determine therapy response in 24 hours

Researchers develop targeted alpha therapy protocol for prostate cancer Determines most effective therapy with the least number of side effects

Eyeing theranostics, Sofie Biosciences completes acquisition of Zevacor Pharma Growth of FDG also influenced decision

Blue Earth Diagnostics partners with GE to manufacture Axumin PET agent in UK Agreements were made in other European countries

RefleXion Medical selects MedCrypt to secure its new radiotherapy technology Updated FDA guidelines put cybersecurity at forefront

PET imaging used for the first time to evaluate Zika virus in mouse model May aid in development of therapeutic agents

Dr. Richard Baum, Theranostics lecturer,
SNMMI 2017

Theranostics takes center stage at SNMMI annual meeting

by John W. Mitchell , Senior Correspondent
At Sunday's opening plenary session for the annual meeting of SNMMI, nuclear medicine and molecular imaging were touted as the premier cutting-edge solutions for personalizing cancer and advancing neurological treatments.

The event, underway in Denver, has brought together roughly 5,000 physicians, other scientists, and technologists.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



"To know the future, first we have to look at the present and immediate past," Dr. Johannes Czernin, Department of Molecular and Medical Pharmacology, Ahmanson Transitional Imaging Division, David Geffen School of Medicine at UCLA told the packed auditorium.

In his talk, titled "Imaging with a Purpose: The Future of Nuclear Medicine, Molecular Imaging Therapy," he described a medical specialty in decline. The number of nuclear medicine programs has dropped from about 90 in the 1990s to about 40 today.

“If you look at the trend line, we’ll be nonexistent by 2050,” he mused. He cited several reasons with the most pressing one being a lack of focus on therapies.

But the good news — as he and the following speaker noted — is that the trend is changing.

PET scan capability (2.5 million performed in 2016, according to Czernin) and new radiotracer compounds are providing revolutionary new views of tumors and neuro cell function.

Theranostics, a combination of therapy and diagnostics, is emerging as a key innovation in tailoring treatments to a patient’s specific case.

“We need to get rid of feelings of inferiority … and promote what we do that works,” Czernin stressed to the crowd.

He shared the current project at UCLA to build a Theranostics Center for outpatient prostate treatment. Specialists who will provide care include urologists, oncologists, endocrinologists and nuclear medicine physicians.

“Radiologists and radiation oncologists are not a good fit for the workflow,” he said, a reference to the new images that can be generated using nuclear imaging to guide treatment specific to each patient.

This sentiment was echoed by Dr. Richard Baum from the Theranostics Center of Excellence for Molecular Radiotherapy, Zentralklinik Bad Berka, Germany, this year’s Henry N. Wegner, Jr. Lecture presenter.

Baum shared several theranostics cases, including one example of detecting low-level prostate cancer. The forming tumor was not indicated by PSA testing, but was captured at 2mm in size with nuclear imaging – something he implied was difficult with traditional imaging.

In his lecture, titled “Theranostics - Looking Back and Moving Forward” he too made the case that new radiotracer applications are revolutionizing cancer care, with personalized treatments — even "curing the incurable." He spoke specifically of the success of the radio tracer Ga-68 in providing new views and treatments of tumors. Baum also said that theranostics is shifting the focus of treatment for cancer away from the organ where the cancer occurs, to the type of tumor.

Theranostics, he acknowledged, is disruptive – and makes people uncomfortable.

“A new scientific truth is not usually presented in a way that convinces opponents,” Baum said, quoting the German theoretical physicist Max Planck, who won a Noble Peace Prize in 1918. “Rather, the opponents die off, and a rising generation becomes familiar with the truth from the start.”

He proposed that the new and young researchers at the SNMMI meeting were the "rising generation."

In other developments from the opening session, neurosurgeon Dr. Julian E. Bailes – who was portrayed by actor Alec Baldwin in the 2015 movie Concussion about brain injury among NFL players – announced a new $25 million fund to research traumatic brain injury on brain function. The SAFTIE (Scanning to Assess for Traumatic Injury and Encephalopathy) grants will include research on new brain imaging agents.

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2017 DOTmed.com, Inc.
ALL RIGHTS RESERVED